![Jay Skyler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Skyler
Directeur/Membre du Conseil chez
SAB BIOTHERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
Jay S.
Skyler currently serves as Deputy Director & Professor at the Diabetes Research Institute since 2012, Director at Moerae Matrix, Inc., Independent Director at SAB Biotherapeutics, Inc. since 2024, and Professor at the University of Miami since 2004.
Former roles include Independent Director at Amylin Pharmaceuticals, Inc. from 2011 to 2012, Independent Director at DexCom, Inc. from 2002 to 2023, Director at Aerami Therapeutics, Inc. from 2013 to 2014, Director at MiniMed, Inc., Director at Intarcia Therapeutics, Inc., Independent Director at Applied Therapeutics, Inc., Chairman-Study at the National Institute of Diabetes & Digestive & Kidney Diseases, Chairman-Subspecialty Societies Council at the American College of Physicians, Vice President at the International Diabetes Federation, Editor-in-Chief at the American Diabetes Association, Member-Examining Board at the American Board of Internal Medicine, and President of the Southern Society for Clinical Investigation.
Education includes undergraduate studies at The Pennsylvania State University and a doctorate from Sidney Kimmel Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Jay Skyler
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/05/2024 |
Moerae Matrix, Inc. /Nj/
 Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel therapies | Directeur/Membre du Conseil | - |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
Diabetes Research Institute
 Diabetes Research Institute Aerospace & DefenseElectronic Technology Part of University of Miami, the Diabetes Research Institute is a national organization dedicated to developing a biological cure for diabetes. The company is based in Miami, FL. | Corporate Officer/Principal | 01/01/1976 |
Anciens postes connus de Jay Skyler
| Sociétés | Poste | Fin |
|---|---|---|
| DEXCOM, INC. | Directeur/Membre du Conseil | 18/05/2023 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Directeur/Membre du Conseil | 08/08/2012 |
MiniMed, Inc.
 MiniMed, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and distributes advanced infusion systems | Directeur/Membre du Conseil | 01/01/2001 |
International Diabetes Federation
 International Diabetes Federation Miscellaneous Commercial ServicesCommercial Services Operates as a diabetes community | Corporate Officer/Principal | - |
Southern Society for Clinical Investigation | President | - |
Formation de Jay Skyler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
MiniMed, Inc.
MiniMed, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and distributes advanced infusion systems | Health Technology |
International Diabetes Federation
International Diabetes Federation Miscellaneous Commercial ServicesCommercial Services Operates as a diabetes community | Commercial Services |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
National Institute of Diabetes & Digestive & Kidney Diseases
 National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Government |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Society for Clinical Investigation | |
Diabetes Research Institute
Diabetes Research Institute Aerospace & DefenseElectronic Technology Part of University of Miami, the Diabetes Research Institute is a national organization dedicated to developing a biological cure for diabetes. The company is based in Miami, FL. | Electronic Technology |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
American College of Physicians
 American College of Physicians Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization | Commercial Services |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Moerae Matrix, Inc. /Nj/
Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel therapies | Commercial Services |
Choisissez Zonebourse 
